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Support for biomedical research and protection of
human subjects in that research are primarily federal
responsibilities. However, primacy does not necessarily
mean exclusivity. Although sometimes overlooked,
state laws play an important role either by extending
the reach of human subjects protection beyond that
afforded under federal law, addressing issues left open
by federal regulation, or determining which types of
research to encourage or prohibit.

Under the Common Rule, federally funded or
conducted research must comply with regulations
aimed at protecting human subjects.
Similarly,
researchers may submit research to the Food and Drug
Administration (FDA) in support of an application
for approval of a drug or device only if such research
adhered to the protections for human subjects in FDA
regulations. 2
These parallel regulatory schemes
include the following essential elements: (1) voluntary
informed consent; (2) the provision of information
enabling intelligent choice by potential subjects, free
of coercion or undue influence; (3) review by an
institutional review board (IRB), a group independent
of the researchers; and (4) an IRB determination that
the benefits potentially derived from the research
justify the risks to research subjects.
Important gaps and limitations characterize this federal
regulatory regime. Specifically, core protections in
the Common Rule and FDA regulations, including
additional regulatory protections for prisoners and
children, do not extend to privately funded and
conducted research not used in an application to the
FDA. Additionally, these regulations do not afford a
remedy to individuals who may have been harmed as a
result of their participation in research. Also, some of
the protections are just plain vague (such as an IRB's
duty to include "additional safeguards" for vulnerable
subjects). 3 Other issues are left unaddressed (for
example, circumstances under which an individual
incapable of giving informed consent may nonetheless
become a research subject).
Federal regulations are modest in recognizing that state
law may serve to fill in these gaps. The Common Rule
is explicitly non-preemptive: the regulations do not

affect state laws that "provide additional protections for
human subjects" or that "require additional information
. . . for informed consent to be legally effective."4
Similar language also appears in FDA regulations.'
Accordingly, preserving a state's role in the protection
of human subjects appropriately recognizes the state
traditional police power.
Under the rubric of additional protections, four states California, Maryland, New York, and Virginia - impose
an informed consent requirement for all research,
including privately funded research. 6 Three of these
states - Maryland, New York, and Virginia - require IRB
review for all research.' In addition, many state laws
provide additional protections forvulnerable populations.
At least five states prohibit using prison inmates for
"medical, pharmaceutical, or cosmetic experiments,"
although these individuals may participate in research
that is "medically appropriate for a specific inmate." 8
Also, to protect nursing home residents, states frequently
grant residents an explicit right to refuse to participate in
experimental research or require that informed consent
be obtained prior to a resident's research participation.

State tort law potentially affords subjects a means of
compensation for research harms. In comparison,
federal regulations neither require compensation in the
event of injury nor create a private right of action to seek
compensation; they merely require disclosure about
the extent of available compensation, which may be
nothing. State common law fills this void by specifying
a researcher's duty to subjects and the circumstances
under which a breach of this duty occurs.
In one respect, state research liability law is wellestablished, arising from ad hoc experimentation
during the course of clinical care. As a New York
court observed more than a century ago in Carpenter
v. Blake, when standard therapy exists, "there should
be no departure from it, unless the surgeon who does
it is prepared to take the risk of establishing by his
success the propriety and safety of his experiment." 9
Similar cases also highlighted this point: in the clinical
setting. the patient is entitled to expect the skillful
application of standard therapy.'o Consequently, the
use of experimental treatment that harms the patient

gives rise to negligence claims, unless the patient properly consented to
the procedure.
More recent cases often focus on alleged deficiencies in the informed
consent process. In Daum v. Spinecare Medical Group, Inc., the plaintiff
alleged that his physicians failed to obtain his informed consent to implant
an experimental, spinal-fixation device." The California Court of Appeals
held that the jury should have been allowed to consider all of the evidence,
not just expert testimony, in deciding whether his physicians breached the
standard of care.' 2 In particular, the jury should have considered the effect
of federal and California informed consent requirements.' 3 Because the
physician-investigators had agreed to comply with FDA regulations, the
regulations themselves established the standard of care. The Court then
held that the plaintiff had "presented sufficient evidence that his injury
resulted from the kind of occurrence the statutes and regulations ... were
intended to prevent: participation in a clinical trial without the subject's
fully informed consent in writing, with a copy for the subject and under
circumstances permitting a free and deliberate choice."' 4 Under this
analysis, failure to adhere to regulatory standards for informed consent
amount to the tort of "research negligence."
In Moore v. Regents ofthe University of California,the California Supreme
Court suggests that some courts view informed consent as requiring
disclosure not only of the protocol-related information specified in the
Common Rule but also of any material economic incentives that affect the
researcher.'" Moore, also arising in a clinical setting, held that a physician
who used a patient's surgically removed spleen to create a patented cell
line should have disclosed his research and economic interests to the
patient prior to removing the spleen.' 6
A research negligence claim might also arise if research procedures are
carried out in a different manner than described in the informed consent
document." In Grimes v. Kennedy, in controversial dicta, the Maryland
Court of Appeals also laid the basis for claims that proxy consent (here,
of a parent on behalf of a child), although permissible under the federal
regulations, was deficient as a matter of state law and hence invalid.'"

If states deem that a particular type of research endeavor - human
cloning, for example - is contrary to sound public policy, they are free
to ban the research altogether. However, if a state's public policy favors
embryonic stem-cell research, which some scientists seek to pursue using
cloning techniques, a ban on cloning can be drafted to exclude those
techniques from the ban. Indeed, several states have gone even further
by using public funds to support the kind of embryonic stem-cell research
denied federal funding under the policies of the Bush Administration.
For example, California has established a state-funded Institute for
Regenerative Medicine, which will support "open-ended, investigatordriven research related to stem cells" that is now hampered by "limited
federal support."' 9
States may also facilitate research in more subtle ways. Laws protecting
the confidentiality of medical records or mandating the reporting of
certain diseases to a state registry, invariably allow access by researchers.
Similarly, vital records laws typically have a broadly phrased research
exception to their confidentiality requirements. For example, Illinois

mandates the reporting of'Reye's Syndrome cases which allows individually
identifiable data available for "health-related research" to researchers who
agree not to redisclose the data.10 Also, public records laws, which always
exempt individual health and other sensitive information from mandatory
disclosure, usually allow researchers access to this information if they
agree to protect the confidentiality of the records.
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